Abstract

The COVID-19 pandemic, with its much wider, faster prevalence compared to other pandemics, has caused widespread disruptions in supply chains that have made supply chain recovery more difficult. In this study, the impact of the disruptions brought about by this global crisis on both the supply-side and the demand-side components are evaluated simultaneously. In particular, the COVID-19 pandemic has negatively affected health commodity supply chains. Moreover, this study examines the financing problems arising from disruptions, as supply chains are bound to experience shortages of liquidity and working capital during such periods. In addition, we consider the pricing mechanism of commodities and the potential impact of innovative sales techniques. In the end, we redesign a health commodity supply chain in view of the adverse impact of the pandemic to make optimal decisions using the available financing sources to ensure higher sales and profitability in the supply chain.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call